NCT02276755View on ClinicalTrials.gov

Vitamin D Supplementation in TB Prevention

PHASE3CompletedINTERVENTIONAL
Enrollment

8,851

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2020

Conditions
Latent Tuberculosis
Interventions
DIETARY_SUPPLEMENT

Cholecalciferol (vitamin D3)

14000 IU vitamin D3 weekly Experimental group will receive vitamin D supplement (Tishcon, USA).

OTHER

Placebo

Placebo group will receive placebo (Tishcon, USA) weekly.

Trial Locations (1)

Unknown

Mongolian Health Initiative, Ulaanbaatar

All Listed Sponsors
lead

Harvard School of Public Health (HSPH)

OTHER

NCT02276755 - Vitamin D Supplementation in TB Prevention | Biotech Hunter | Biotech Hunter